Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

Risk of serious neurologic disease after immunization of young children in Britain and Ireland.

Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, Verity CM, Ross EM, Miller E.

Pediatrics. 2007 Aug;120(2):314-21.

PMID:
17671057
2.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team..

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
3.

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML.

Am J Epidemiol. 2000 Mar 1;151(5):524-30.

PMID:
10707922
4.

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E.

Lancet. 1995 Mar 4;345(8949):567-9.

PMID:
7619183
5.

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.

Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R.

Pediatr Infect Dis J. 1997 May;16(5):500-3.

PMID:
9154545
6.

Post-licensure safety of the meningococcal group C conjugate vaccine.

Andrews N, Stowe J, Miller E, Taylor B.

Hum Vaccin. 2007 Mar-Apr;3(2):59-63. Epub 2007 Mar 17.

PMID:
17312400
7.

Risk of seizures after measles-mumps-rubella immunization.

Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W.

Pediatrics. 1991 Nov;88(5):881-5.

PMID:
1945626
8.
9.

Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

Nakayama T, Onoda K.

Vaccine. 2007 Jan 5;25(3):570-6. Epub 2006 Aug 4.

PMID:
16945455
11.

Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.

Groves FD, Gridley G, Wacholder S, Shu XO, Robison LL, Neglia JP, Linet MS.

Br J Cancer. 1999 Sep;81(1):175-8.

12.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
14.

Illness after measles-mumps-rubella vaccination.

Freeman TR, Stewart MA, Turner L.

CMAJ. 1993 Dec 1;149(11):1669-74.

16.

Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey.

McLaughlin M, Thomas P, Onorato I, Rubinstein A, Oleske J, Nicholas S, Krasinski K, Guigli P, Orenstein W.

Pediatrics. 1988 Aug;82(2):229-33.

PMID:
3399296
17.
19.

Revaccination of children after completion of standard chemotherapy for acute leukemia.

Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT.

Clin Infect Dis. 2007 Mar 1;44(5):635-42. Epub 2007 Jan 24.

PMID:
17278052
20.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group..

N Engl J Med. 2001 Aug 30;345(9):656-61.

Supplemental Content

Support Center